Bayer Nails Down Deal To Share Ex-U.S. Rights For Wet AMD Treatment
Agreement with Regeneron includes joint development and commercialization of VEGF-Trap Eye for wet AMD and diabetic macular edema.
Agreement with Regeneron includes joint development and commercialization of VEGF-Trap Eye for wet AMD and diabetic macular edema.